statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investopedia

 Key TakeawaysThe S&P 500 gained 0.9% on Thursday, May 2, 2024, as concerns subsided about a possible rate hike and ahead of Friday's jobs report.Paramount Global shares gained amid...

S&P 500 Gains and Losses Today: Etsy Drops Amid Sluggish Discretionary Spending

The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years. Read More...

Moderna's sales from its only product, the COVID-19 vaccine, fell 91% from last year

Markets Chop As Wall Street Awaits Apple Earnings After Bell, NFP Friday For Market Direction

 US equities ended their two-day slide as tech companies surged late in the session. The...

Markets Chop As Wall Street Awaits Apple Earnings After Bell, NFP Friday For Market Direction

S&P 500, Nasdaq Rise Intraday Amid Moderna Rally as Traders Await Apple Results...

S&P 500, Nasdaq Rise Intraday Amid Moderna Rally as Traders Await Apple Results

Moderna CEO talks Q1 earnings, Brazil COVID vaccine, and cancer treatment markets...

Moderna CEO talks Q1 earnings, Brazil COVID vaccine, and cancer treatment markets

Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism for investors. CEO St phane Bancel eyes strategic investments. Guidance...

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars

Bloomberg / Contributor / Getty Images

 Key TakeawaysU.S. equities were higher at midday as the markets weighed Fed Chair Powell's comments about the future of interest rates.Moderna's net loss...

Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More

Moderna Focused on Cutting Costs, RSV Vaccine...

Moderna Focused on Cutting Costs, RSV Vaccine

Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot...

Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.

C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Volume	1,230.00
52-Wk High	$142.79
52-Wk Low	$62.55

Period	Estimated	Reported	Surprise	Result
Q2'24	-$3.45	--	--	N/A
Q1'24	-$3.56	-$3.07	13.68%	BEAT
Q4'23	-$0.93	$0.55	159.23%	BEAT
Q3'23	-$1.93	-$9.53	-393.19%	MISSED
Q2'23	-$3.93	-$3.62	8.00%	BEAT

MRNA Moderna Inc

About

Feed

News

Sentiment

Earnings

Fundamentals